Rachel Vaknin
2023
In 2023, Rachel Vaknin earned a total compensation of $289.5K as CFO at StemCells, a 23% increase compared to previous year.
Compensation breakdown
| Bonus | $27,626 |
|---|---|
| Option Awards | $76,533 |
| Salary | $139,601 |
| Other | $45,743 |
| Total | $289,503 |
Vaknin received $139.6K in salary, accounting for 48% of the total pay in 2023.
Vaknin also received $27.6K in bonus, $76.5K in option awards and $45.7K in other compensation.
Rankings
In 2023, Rachel Vaknin's compensation ranked 2,434th out of 2,811 executives tracked by ExecPay. In other words, Vaknin earned more than 13.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,434 out of 2,811 | 13th |
Division Manufacturing | 1,356 out of 1,548 | 12th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 202 out of 237 | 15th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 142 out of 172 | 17th |
Industry Surgical and Medical Instruments and Apparatus | 111 out of 132 | 16th |
Source: SEC filing on November 6, 2024.
Vaknin's colleagues
We found three more compensation records of executives who worked with Rachel Vaknin at StemCells in 2023.